Analysed HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) News Sources
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets
11-03-2026
yahoo.com
Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
09-03-2026
yahoo.com
Terns Pharmaceuticals (TERN) Valuation Check After Expanded Global Rights To TERN-701
03-02-2026
yahoo.com
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
03-02-2026
yahoo.com
Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment
02-02-2026
yahoo.com
Hansoh Pharmaceutical Group (SEHK:3692) Valuation: Is Recent Momentum Supported by the Fundamentals?
10-09-2025
yahoo.com
China's healthcare sector sees record US$10.6 billion fundraising as biotech booms
10-09-2025
yahoo.com
What is the current price of HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS)?
The current price of HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) is $5.16.
HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) since the previous trading day is $0.
HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS)?
The most recent average sentiment score for HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS)?
The most recent sentiment for HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS) is .
SEC-8K** Filing Available For HANSOH PHARMACEUTICAL GROUP (HNSPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.